116 related articles for article (PubMed ID: 7212947)
1. Chlorpromazine levels and the outcome of treatment in schizophrenic patients.
May PR; Van Putten T; Jenden DJ; Yale C; Dixon WJ
Arch Gen Psychiatry; 1981 Feb; 38(2):202-7. PubMed ID: 7212947
[TBL] [Abstract][Full Text] [Related]
2. Test dose response in schizophrenia: chlorpromazine blood and saliva levels.
May PR; Van Putten T; Jenden DJ; Cho AK
Arch Gen Psychiatry; 1978 Sep; 35(9):1091-7. PubMed ID: 686971
[TBL] [Abstract][Full Text] [Related]
3. Plasma and saliva levels of chlorpromazine and subjective response.
Van Putten T; May PR; Jenden DJ; Cho AK; Yale C
Am J Psychiatry; 1980 Oct; 137(10):1241-2. PubMed ID: 7416274
[TBL] [Abstract][Full Text] [Related]
4. Does a plasma level of chlorpromazine help?
Van Putten T; May PR; Jenden DJ
Psychol Med; 1981 Nov; 11(4):729-34. PubMed ID: 6119719
[TBL] [Abstract][Full Text] [Related]
5. Total and free plasma neuroleptic levels in schizophrenic patients.
Tang SW; Glaister J; Davidson L; Toth R; Jeffries JJ; Seeman P
Psychiatry Res; 1984 Dec; 13(4):285-93. PubMed ID: 6596586
[TBL] [Abstract][Full Text] [Related]
6. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.
Wode-Helgodt B; Borg S; Fyrö B; Sedvall G
Acta Psychiatr Scand; 1978 Aug; 58(2):149-73. PubMed ID: 358755
[TBL] [Abstract][Full Text] [Related]
7. Predicting outcome of antipsychotic drug treatment from early response.
May PR; Van Putten T; Yale C
Am J Psychiatry; 1980 Sep; 137(9):1088-9. PubMed ID: 7425161
[TBL] [Abstract][Full Text] [Related]
8. Correlation between plasma concentrations of chlorpromazine and clinical response.
Rivera-Calimlim L; Gift T; Nasrallah HA; Wyatt RJ; Lasagna L
Commun Psychopharmacol; 1978; 2(3):215-22. PubMed ID: 699536
[No Abstract] [Full Text] [Related]
9. Prediction of drug responses in schizophrenia: a method using a test dose of chlorpromazine.
Minami H; Nakahara T; Miyahara A; Nakane Y
Psychiatry Clin Neurosci; 1997 Aug; 51(4):217-22. PubMed ID: 9316167
[TBL] [Abstract][Full Text] [Related]
10. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics.
Rockland L; Cooper T; Schwartz F; Weber D; Sullivan T
Can J Psychiatry; 1990 Oct; 35(7):604-7. PubMed ID: 2268840
[TBL] [Abstract][Full Text] [Related]
11. Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis.
Phillipson OT; McKeown JM; Baker J; Healey AF
Br J Psychiatry; 1977 Aug; 131():172-84. PubMed ID: 912219
[TBL] [Abstract][Full Text] [Related]
12. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
[TBL] [Abstract][Full Text] [Related]
13. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
Meltzer HY; Busch DA; Fang VS
Psychiatry Res; 1983 Aug; 9(4):271-83. PubMed ID: 6580660
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of chlorpromazine in schizophrenia; a critical review of the literature.
May PR; Van Putten T
Arch Gen Psychiatry; 1978 Sep; 35(9):1081-7. PubMed ID: 686970
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
[TBL] [Abstract][Full Text] [Related]
16. Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison.
Shopsin B; Klein H; Aaronsom M; Collora M
Arch Gen Psychiatry; 1979 Jun; 36(6):657-64. PubMed ID: 375865
[TBL] [Abstract][Full Text] [Related]
17. Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine.
Adamson L; Curry SH; Bridges PK; Firestone AF; Lavin NI; Lewis DM; Watson RD; Xavier CM; Anderson JA
Dis Nerv Syst; 1973; 34(4):181-91. PubMed ID: 4711886
[No Abstract] [Full Text] [Related]
18. Promazine. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics.
Sgaragli G; Ninci R; Della Corte L; Valoti M; Nardini M; Andreoli V; Moneti G
Drug Metab Dispos; 1986; 14(2):263-6. PubMed ID: 2870904
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine : A Review of its Use in Schizophrenia.
Gunasekara NS; Spencer CM
CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
[TBL] [Abstract][Full Text] [Related]
20. Change in "overinclusive" thinking of schizophrenic patients is related to plasma phenothiazine concentration.
Phillipson OT; Baker J; Williams M
Adv Biochem Psychopharmacol; 1980; 24():591-7. PubMed ID: 6105805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
